This section presents a list of current and upcoming funding opportunities by large funding agencies relevant to researchers in Sweden who work on COVID-19, infectious diseases, and antibiotic resistance. We focus on topic-specific calls but general funding calls for medicine and health as well as life science grants are listed as well. NB: This list is manually curated so it is possible that some calls are not listed. If you would like for a call to be listed here, please send us an email to datacentre@scilifelab.se. For a list of recurring funding calls, see the text below.
Open funding opportunities
Last updated: 2023-01-16
Topic
Antibiotic resistance
COVID-19
General
Infectious diseases
Monkeypox
Funder
Hedlunds Stifelse
Horizon Europe
ISIDORe
JPIAMR
NordForsk
Scandinavian Society of Antimicrobial Chemotherapy Foundation
The purpose of the grant is to support international collaboration in the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). This is the 16th call within JPIAMR and has the …
Project grant for international research collaboration within antimicrobial resistance (Swedish project leader’s application in Prisma).
Funder: JPIAMR Submission opens:
January 16, 2023 Submission deadline: March 14, 2023 Funding amount: Minimum 1 200 000 SEK (approximately 110 000 EUR) in total per Swedish partner in a project. Maximum 3 500 000 SEK in total (approximately 320 000 EUR) per project for Swedish participation with maximum 2 Swedish partners. Maximum 5 000 000 SEK in total (approximately 457 000 EUR) for Swedish participation in a consortium with a Swedish coordinator. Funding period: 3 years starting Jan 2024. Eligible applicant:
ndividual researcher who participates as 1 of maximum 2 Swedish project leaders in a consortium with partners from at least 3 participating countries. Only researchers at an administrating organisation approved by the Swedish Research Council may apply. Decision date: No later than the end of November 2023.
Call description: The purpose of the grant is to support international collaboration in the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). This is the 16th call within JPIAMR and has the title “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”. Sweden, via the Swedish Research Council, the Swedish International Development Cooperation Agency, is one of the 19 countries taking part in the JPIAMR call.
The purpose of the grant is to support international collaboration in the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). This is the 16th call within JPIAMR and has the …
Project grant for international research collaboration within antimicrobial resistance (consortium application to JPIAMR).
Funder: JPIAMR Submission opens:
January 16, 2023 Submission deadline: March 7, 2023 Funding amount: Minimum 1 200 000 SEK (approximately 110 000 EUR) in total per Swedish partner in a project. Maximum 3 500 000 SEK in total (approximately 320 000 EUR) per project for Swedish participation with maximum 2 Swedish partners. Maximum 5 000 000 SEK in total (approximately 457 000 EUR) for Swedish participation in a consortium with a Swedish coordinator. Funding period: 3 years starting Jan 2024. Eligible applicant:
ndividual researcher who participates as 1 of maximum 2 Swedish project leaders in a consortium with partners from at least 3 participating countries. Only researchers at an administrating organisation approved by the Swedish Research Council may apply. Decision date: No later than the end of November 2023.
Call description: The purpose of the grant is to support international collaboration in the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). This is the 16th call within JPIAMR and has the title “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”. Sweden, via the Swedish Research Council, the Swedish International Development Cooperation Agency, is one of the 19 countries taking part in the JPIAMR call.
The Foundation distributes grants for research or travel related to the treatment of infectious diseases with antibacterial, antiviral, antimycotic or antiparasitic agents. The assets of the …
Scandinavian Society of Antimicrobial Chemotherapy Foundation (SSAC Foundation) grants
Funder: Scandinavian Society of Antimicrobial Chemotherapy Foundation Submission opens:
December 1, 2022 Submission deadline: February 1, 2023 Funding period: The grant should have been used by the end of December the year after the grant was received. Extension of the grant disposal time can only be approved under exceptional circumstances. Eligible applicant:
Applicants must be members of the Nordic Society of Clinical Microbiology and Infectious Diseases, NSCMID. The membership must have been granted no later than November 1st the year before the application. Decision date: Decisions on the grants will be communicated to the applicants via email by end of June.
Call description: The Foundation distributes grants for research or travel related to the treatment of infectious diseases with antibacterial, antiviral, antimycotic or antiparasitic agents. The assets of the Foundation originates from the earnings of the 18th International Congress of Chemotherapy in Stockholm in 1993.
Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe's services, falls under topics defined in the Scope (see funding link for details), …
Risk Group 4 Pathogens
Funder: ISIDORe Submission opens:
November 1, 2022 Submission deadline: February 7, 2023 Funding amount: Call provides access to ISIDORe services, not a given monetary amount.
Call description: Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe’s services, falls under topics defined in the Scope (see funding link for details), and/or is focused on at least one eligible RG4 pathogen (see funding link for details). Your proposal must focus on at least one of the following pathogens; Ebola virus, Marburg virus, Nipah virus, Hendra virus, Lassa virus, ’new world arenaviruses’, CCHF virus.
Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe's services, falls under topics defined in the Scope (see funding link for details), …
Respiratory Pathogens
Funder: ISIDORe Submission opens:
November 1, 2022 Submission deadline: January 1, 2025 Funding amount: Funding will be available for as long as it remains available. Call provides access to ISIDORe services, not a given monetary amount.
Call description: Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe’s services, falls under topics defined in the Scope (see funding link for details), and/or is focused on at least one eligible respiratory pathogen (see funding link for details). Your proposal must focus on at least one of the following pathogens: Zoonotic betacoronaviruses, Influenza A, Yersinia pestis, Mycobacterium tuberculosis/bovis, Coxiella burnetii.
Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe's services, falls under topics defined in the Scope (see funding link for details), …
Vector-borne Pathogens and their Vectors
Funder: ISIDORe Submission opens:
November 1, 2022 Submission deadline: January 1, 2025 Funding amount: Funding will be available for as long as it remains available. Call provides access to ISIDORe services, not a given monetary amount.
Call description: Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe’s services, falls under topics defined in the Scope (see funding link for details), and/or is focused on at least one eligible vector-borne pathogen (see funding link for details). Your proposal must focus on at least one of the following pathogens: Rift valley fever virus, Zika virus, Chikungunya virus, West Nile virus, Dengue virus, Japanese encephalitis, Yellow fever virus, Tick-borne encephalitis virus, Plasmodium, Leishmania, Borrelia burgdorferi.
Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe's services, falls under topics defined in the Scope (see funding link for details), …
Other Pathogens with Epidemic Potential
Funder: ISIDORe Submission opens:
November 1, 2022 Submission deadline: January 1, 2025 Funding amount: Funding will be available for as long as it remains available. Call provides access to ISIDORe services, not a given monetary amount.
Call description: Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe’s services, falls under topics defined in the Scope (see funding link for details), and/or is focused on pathogen X or at least one of: Orthopoxviruses, Non-polio enteroviruses, or Polio enteroviruses.
The overall objective of the call is to support research related to brain diseases (including psychiatry), infectious disease, and chronic inflammatory diseases.
Medical Research
Funder: Hedlunds Stifelse Submission opens:
November 1, 2022 Submission deadline: January 31, 2023 Funding period: Applications are approved one year at a time for a maximum of 3 years. Eligible applicant:
A PhD researcher at a Swedish University/college conducting qualified medical research. The funds are paid out to the University/college. Decision date: Following board meeting in April/May 2023.
Call description: The overall objective of the call is to support research related to brain diseases (including psychiatry), infectious disease, and chronic inflammatory diseases.
Your request for free of charge transnational access to ISIDORe services for supporting and advancing your research must be focused on one of; surveillance & epidemic risk management, …
SARS-COV-2 & COVID‑19
Funder: ISIDORe Submission opens:
May 15, 2022 Submission deadline: January 1, 2025 Funding amount: Funding will be available for as long as it remains available. Call provides access to ISIDORe services, not a given monetary amount.
Call description: Your request for free of charge transnational access to ISIDORe services for supporting and advancing your research must be focused on one of; surveillance & epidemic risk management, understanding SARS-CoV- 2 & COVID-19, diagnostics, therapeutics, vaccines, or social sciences & epidemiology.
Generally, the Swedish Research Council starts accepting applications for funding within medicine and health (such as for example the project grant, starting grant and consolidator grant) at the beginning of each year with a deadline in spring. Information about these calls is typically available at the end of the previous year.
Generally, Svenska Sällskapet för Medicinsk Forskning (SSMF) grant applications are accepted during spring. You can find information about funding from SSMF on their website.